159 related articles for article (PubMed ID: 18209064)
1. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D.
Takada A; Yoshida S; Kajikawa M; Miyatake Y; Tomaru U; Sakai M; Chiba H; Maenaka K; Kohda D; Fugo K; Kasahara M
J Immunol; 2008 Feb; 180(3):1678-85. PubMed ID: 18209064
[TBL] [Abstract][Full Text] [Related]
2. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
O'Callaghan CA; Cerwenka A; Willcox BE; Lanier LL; Bjorkman PJ
Immunity; 2001 Aug; 15(2):201-11. PubMed ID: 11520456
[TBL] [Abstract][Full Text] [Related]
3. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.
Bui JD; Carayannopoulos LN; Lanier LL; Yokoyama WM; Schreiber RD
J Immunol; 2006 Jan; 176(2):905-13. PubMed ID: 16393975
[TBL] [Abstract][Full Text] [Related]
4. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
Hasan M; Krmpotic A; Ruzsics Z; Bubic I; Lenac T; Halenius A; Loewendorf A; Messerle M; Hengel H; Jonjic S; Koszinowski UH
J Virol; 2005 Mar; 79(5):2920-30. PubMed ID: 15709011
[TBL] [Abstract][Full Text] [Related]
5. Ligands for murine NKG2D display heterogeneous binding behavior.
Carayannopoulos LN; Naidenko OV; Kinder J; Ho EL; Fremont DH; Yokoyama W
Eur J Immunol; 2002 Mar; 32(3):597-605. PubMed ID: 11857333
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
Cerwenka A; Bakker AB; McClanahan T; Wagner J; Wu J; Phillips JH; Lanier LL
Immunity; 2000 Jun; 12(6):721-7. PubMed ID: 10894171
[TBL] [Abstract][Full Text] [Related]
7. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.
Lodoen MB; Abenes G; Umamoto S; Houchins JP; Liu F; Lanier LL
J Exp Med; 2004 Oct; 200(8):1075-81. PubMed ID: 15477345
[TBL] [Abstract][Full Text] [Related]
8. Involvement of an NKG2D ligand H60c in epidermal dendritic T cell-mediated wound repair.
Yoshida S; Mohamed RH; Kajikawa M; Koizumi J; Tanaka M; Fugo K; Otsuka N; Maenaka K; Yagita H; Chiba H; Kasahara M
J Immunol; 2012 Apr; 188(8):3972-9. PubMed ID: 22403443
[TBL] [Abstract][Full Text] [Related]
9. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S
J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D.
Cerwenka A; O'Callaghan CA; Hamerman JA; Yadav R; Ajayi W; Roopenian DC; Joyce S; Lanier LL
J Immunol; 2002 Apr; 168(7):3131-4. PubMed ID: 11907062
[TBL] [Abstract][Full Text] [Related]
11. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
12. NKG2D-independent suppression of T cell proliferation by H60 and MICA.
Kriegeskorte AK; Gebhardt FE; Porcellini S; Schiemann M; Stemberger C; Franz TJ; Huster KM; Carayannopoulos LN; Yokoyama WM; Colonna M; Siccardi AG; Bauer S; Busch DH
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11805-10. PubMed ID: 16091471
[TBL] [Abstract][Full Text] [Related]
13. MHC class I-like genes in cattle, MHCLA, with similarity to genes encoding NK cell stimulatory ligands.
Larson JH; Rebeiz MJ; Stiening CM; Windish RL; Beever JE; Lewin HA
Immunogenetics; 2003 Apr; 55(1):16-22. PubMed ID: 12679856
[TBL] [Abstract][Full Text] [Related]
14. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
Diefenbach A; Jensen ER; Jamieson AM; Raulet DH
Nature; 2001 Sep; 413(6852):165-71. PubMed ID: 11557981
[TBL] [Abstract][Full Text] [Related]
15. EAE tolerance induction with Hsp70-peptide complexes depends on H60 and NKG2D activity.
Galazka G; Jurewicz A; Orlowski W; Stasiolek M; Brosnan CF; Raine CS; Selmaj K
J Immunol; 2007 Oct; 179(7):4503-12. PubMed ID: 17878346
[TBL] [Abstract][Full Text] [Related]
16. [Effects of NKG2D and its ligands RAE-1 and H60 on graft-versus-tumor response].
Li XF; Chen Q; Ye YB; Fan LF; Chen MS; Li JY; Chen HQ; Chen SP; Zhou ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):160-4. PubMed ID: 17490545
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.
Carayannopoulos LN; Naidenko OV; Fremont DH; Yokoyama WM
J Immunol; 2002 Oct; 169(8):4079-83. PubMed ID: 12370332
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
J Immunol; 2005 Oct; 175(8):5541-50. PubMed ID: 16210663
[TBL] [Abstract][Full Text] [Related]
20. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection.
Feng L; Ke N; Ye Z; Guo Y; Li S; Li Q; Li Y
Transplant Proc; 2009 Dec; 41(10):4332-9. PubMed ID: 20005394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
